Home > Publications Database > Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial. > print

001     278797
005     20250604100731.0
024 7 _ |a 10.1038/s41591-025-03602-0
|2 doi
024 7 _ |a pmid:40181181
|2 pmid
024 7 _ |a pmc:PMC12092257
|2 pmc
024 7 _ |a 1078-8956
|2 ISSN
024 7 _ |a 1546-170X
|2 ISSN
037 _ _ |a DZNE-2025-00633
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Temba, Godfrey S
|b 0
245 _ _ |a Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial.
260 _ _ |a [New York, NY]
|c 2025
|b Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1748946805_5050
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a African heritage diets are increasingly being replaced by Western-style dietary patterns because of urbanization, economic development, increased access to processed foods, globalization and changing social norms. The health consequences of this nutrition transition are not well understood. We conducted a randomized controlled trial in the Kilimanjaro region in Northern Tanzania to investigate the immune and metabolic effects of switching between Kilimanjaro heritage-style and Western-style diets for 2 weeks and consuming a traditional fermented banana beverage ('Mbege') for 1 week. Seventy-seven young and healthy volunteers assigned male at birth, some living in urban areas and some living in rural areas, were recruited in the trial. Primary outcomes were changes in the immune and metabolic profile before and after the intervention and at the 4-week follow-up. The switch from heritage-style to Western-style diet affected different metabolic pathways associated with noncommunicable diseases and promoted a pro-inflammatory state with impaired whole-blood cytokine responses to microbial stimulation. In contrast, the switch from Western-style to heritage-style diet or consuming the fermented beverage had a largely anti-inflammatory effect. Some of the observed changes in the immune and metabolic profiles persisted at the follow-up, suggesting a sustained impact from the short-term intervention. These findings show the metabolic and immune effects of dietary transitions and the consumption of fermented beverages, underscoring the importance of preserving indigenous dietary practices to mitigate noncommunicable disease risk factors in sub-Saharan Africa. ISRCTN trial registration: ISRCTN15619939 .
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Cytokines
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Tanzania
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Diet, Western: adverse effects
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
650 _ 2 |a Diet
|2 MeSH
650 _ 2 |a Musa
|2 MeSH
650 _ 2 |a Adolescent
|2 MeSH
650 _ 2 |a Cytokines: blood
|2 MeSH
693 _ _ |0 EXP:(DE-2719)PRECISE-20190321
|5 EXP:(DE-2719)PRECISE-20190321
|e Platform for Single Cell Genomics and Epigenomics at DZNE University of Bonn
|x 0
700 1 _ |a Pecht, Tal
|0 P:(DE-2719)9002574
|b 1
|e First author
|u dzne
700 1 _ |a Kullaya, Vesla I
|b 2
700 1 _ |a Vadaq, Nadira
|0 0000-0002-1746-8844
|b 3
700 1 _ |a Mosha, Mary V
|b 4
700 1 _ |a Ulas, Thomas
|0 P:(DE-2719)9000845
|b 5
700 1 _ |a Kanungo, Sneha
|0 P:(DE-2719)9003109
|b 6
|u dzne
700 1 _ |a van Emst, Liesbeth
|b 7
700 1 _ |a Bonaguro, Lorenzo
|0 P:(DE-2719)9001512
|b 8
|u dzne
700 1 _ |a Schulte-Schrepping, Jonas
|0 P:(DE-2719)9001500
|b 9
|u dzne
700 1 _ |a Mafuru, Elias
|0 0000-0002-6980-8767
|b 10
700 1 _ |a Lionetti, Paolo
|0 0000-0001-8029-3904
|b 11
700 1 _ |a Mhlanga, Musa M
|0 0000-0003-1381-3409
|b 12
700 1 _ |a van der Ven, Andre J
|0 0000-0003-1833-3391
|b 13
700 1 _ |a Cavalieri, Duccio
|0 0000-0001-6426-5719
|b 14
700 1 _ |a Joosten, Leo A B
|0 0000-0001-6166-9830
|b 15
700 1 _ |a Kavishe, Reginald A
|0 0000-0001-9147-5295
|b 16
700 1 _ |a Mmbaga, Blandina T
|0 0000-0002-5550-1916
|b 17
700 1 _ |a Schultze, Joachim L
|0 P:(DE-2719)2811660
|b 18
700 1 _ |a Netea, Mihai G
|0 0000-0003-2421-6052
|b 19
700 1 _ |a de Mast, Quirijn
|0 0000-0001-6056-157X
|b 20
773 _ _ |a 10.1038/s41591-025-03602-0
|g Vol. 31, no. 5, p. 1698 - 1711
|0 PERI:(DE-600)1484517-9
|n 5
|p 1698 - 1711
|t Nature medicine
|v 31
|y 2025
|x 1078-8956
856 4 _ |u https://pub.dzne.de/record/278797/files/DZNE-2025-00633%20SUP1.pdf
856 4 _ |u https://pub.dzne.de/record/278797/files/DZNE-2025-00633%20SUP2.pdf
856 4 _ |u https://pub.dzne.de/record/278797/files/DZNE-2025-00633%20SUP3.xlsx
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/278797/files/DZNE-2025-00633.pdf
856 4 _ |x pdfa
|u https://pub.dzne.de/record/278797/files/DZNE-2025-00633%20SUP1.pdf?subformat=pdfa
856 4 _ |x pdfa
|u https://pub.dzne.de/record/278797/files/DZNE-2025-00633%20SUP2.pdf?subformat=pdfa
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/278797/files/DZNE-2025-00633.pdf?subformat=pdfa
856 4 _ |u https://pub.dzne.de/record/278797/files/DZNE-2025-00633%20SUP3.xls
909 C O |o oai:pub.dzne.de:278797
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002574
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9000845
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9003109
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9001512
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9001500
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)2811660
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-06
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT MED : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-06
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-06
915 _ _ |a IF >= 80
|0 StatID:(DE-HGF)9980
|2 StatID
|b NAT MED : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-06
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 1 _ |0 I:(DE-2719)1013038
|k AG Schultze
|l Clinical Single Cell Omics (CSCO) / Systems Medicine
|x 0
920 1 _ |0 I:(DE-2719)1013031
|k PRECISE
|l Platform for Single Cell Genomics and Epigenomics
|x 1
920 1 _ |0 I:(DE-2719)1016005
|k AG Bonaguro
|l Molecular and Translational Immunaging
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013038
980 _ _ |a I:(DE-2719)1013031
980 _ _ |a I:(DE-2719)1016005
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21